The Merlin team had a very successful plenary in Rotterdam on 10 and 11 May. Updates were presented on each WP. MSC production and preparation for the upcoming trial were naturally a key focus at this stage of the project. Publications and plans for future work were also discussed. Many thanks to EMC for hosting and to all the partners for their input into a very productive and enjoyable meeting!
- Advancing Therapies | This report highlights the acceleration of cell and gene therapy approvals worldwide t.co/4xSTJvD7ha Time ago 17 Days via Twitter Web Client
- RT @PintailLimited: PROJECT HIGHLIGHT: @VISICORT PI Prof John Armitage, of University of Bristol awarded an OBE in the Queen’s New Year Ho… Time ago 21 Days via Twitter Web Client
- Our @FP7Merlin partners @Orbsen Therapeutics are hiring a Senior #GMP Production Scientist for production in… t.co/SLsfNK61iW Time ago 21 Days via Twitter Web Client
Follow @fp7merlin on twitter.
This project has received funding from the European Union’s Seventh Framework Programme for research, technological development and demonstration under grant agreement no 602363. The material presented and views expressed here are the responsibility of the author(s) only. The EU Commission takes no responsibility for any use made of the information set out.